Literature DB >> 18458716

Improvement of neuropsychiatric symptoms in multiple sclerosis subsequent to high-dose corticosteroid treatment.

Jan Thöne, Elke Kessler.   

Abstract

Entities:  

Year:  2008        PMID： 18458716      PMCID： PMC2292428          DOI： 10.4088/pcc.v10n0213e

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  5 in total

Review 1.  Psychiatric adverse effects of corticosteroids.

Authors:  Thomas P Warrington; J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2006-10       Impact factor: 7.616

2.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  C Diaz-Olavarrieta; J L Cummings; J Velazquez; C Garcia de la Cadena
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

3.  Antipsychotic treatment of psychosis associated with multiple sclerosis.

Authors:  Eugen Davids; Ulrike Hartwig; Markus Gastpar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-07       Impact factor: 5.067

4.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

5.  Multiple sclerosis presenting with acute remitting psychiatric symptoms.

Authors:  W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-09       Impact factor: 10.154
  5 in total
  1 in total

1.  Psychotic reaction as a manifestation of multiple sclerosis relapse treated with plasma exchange.

Authors:  Tereza Gabelić; Ivan Adamec; Anamarija Mrđen; Milan Radoš; Vesna V Brinar; Mario Habek
Journal:  Neurol Sci       Date:  2011-07-28       Impact factor: 3.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.